Connecting you to content on EBSCOhost

Works by Angi, Réka

Results: 4

1

Novel formulation of abiraterone acetate might allow significant dose reduction and eliminates substantial positive food effect.

Published in:

2017

By:

Solymosi, Tamás;
Ötvös, Zsolt;
Angi, Réka;
Ordasi, Betti;
Jordán, Tamás;
Molnár, László;
McDermott, John;
Zann, Vanessa;
Church, Ann;
Mair, Stuart;
Filipcsei, Genovéva;
Heltovics, Gábor;
Glavinas, Hristos;
Solymosi, Tamás;
Ötvös, Zsolt;
Angi, Réka;
Jordán, Tamás;
Molnár, László;
Filipcsei, Genovéva;
Heltovics, Gábor

Publication type:

journal article

2

Study of the Influence of Pharmaceutical Excipients on the Solubility and Permeability of BCS Class II Drugs.

Published in:

Scientia Pharmaceutica, 2025, v. 93, n. 2, p. 19, doi. 10.3390/scipharm93020019

By:

Bárdos, Vivien;
Szolláth, Rita;
Tőzsér, Petra;
Mirzahosseini, Arash;
Sinkó, Bálint;
Angi, Réka;
Takács-Novák, Krisztina

Publication type:

Article

3

Dose Finding and Food Effect Studies of a Novel Abiraterone Acetate Formulation for Oral Suspension in Comparison to a Reference Formulation in Healthy Male Subjects.

Published in:

Pharmaceutics, 2021, v. 13, n. 12, p. 2171, doi. 10.3390/pharmaceutics13122171

By:

Jordán, Tamás;
Basa-Dénes, Orsolya;
Angi, Réka;
Orosz, János;
Ötvös, Zsolt;
Ujhelyi, Andrea;
Filipcsei, Genovéva;
Molnár, László;
Solymosi, Tamás;
Glavinas, Hristos;
Capone, Dominic;
Whitfield, Nicola;
McDermott, John;
McKenzie, Litza;
Shurety, Lauren;
Duus, Elizabeth Manning

Publication type:

Article

4

Preparation, Pre-clinical and Clinical Evaluation of a Novel Rapidly Absorbed Celecoxib Formulation.

Published in:

AAPS PharmSciTech, 2019, v. 20, n. 2, p. 1, doi. 10.1208/s12249-018-1270-2

By:

Angi, Réka;
Solymosi, Tamás;
Erdősi, Nikoletta;
Jordán, Tamás;
Kárpáti, Balázs;
Basa-Dénes, Orsolya;
Ujhelyi, Andrea;
McDermott, John;
Roe, Chris;
Mair, Stuart;
Ötvös, Zsolt;
Molnár, László;
Glavinas, Hristos

Publication type:

Article